European crop protection markets are being fundamentally reshaped by EU regulation. While high environmental and health standards remain broadly supported, increasingly restrictive approval frameworks for crop protection products have altered innovation incentives, accelerated the loss of active ingredients and intensified competition. As a result, market dynamics are shifting towards post-patent products, commonly referred to as generics.
This regulatory-driven transformation has fueled price competition across key European agricultural markets, reinforcing the dominance of generics and increasing pressure along the entire value chain. This article examines how EU regulation has become the central driver of the current price war in crop protection and analyzes how these market dynamics challenge long-term innovation, economic viability and the resilience of sustainable European agriculture.
The EU crop protection sector is at a pivotal moment. Europe’s regulatory framework is the strictest in the world, and it is designed to safeguard human health, biodiversity and the environment. While these objectives enjoy broad support, the cumulative impact of the rules is reshaping competition, pricing and innovation across the continent. For companies that supply active ingredients, formulations and R&D services, the challenge is no longer “sustainability versus crop protection” but how to make both thrive in a resilient food system.
Regulations
EU Regulation (EC) No 1107/2009 governs the approval of active substances and the authorization of plant‑protection products. Under this regulation, each active substance must be re‑evaluated every ten to fifteen years, and a non‑renewal forces the withdrawal of all products that contain the substance. In recent years only a handful of new active substances—mainly low‑risk biologics—have received approval, while many legacy chemicals have been phased out. Because the development of entirely new chemistry now involves high cost and long timelines, many innovators have redirected their R&D toward improved formulations, product‑mixes and biological solutions.
Post-Patents
A wave of patent expirations on long‑standing active ingredients is opening the market to generic manufacturers. The regulatory pathway for a generic product is considerably less costly than for a brand‑new chemistry, which enables rapid and extensive entry of off‑patent solutions. As a result, the share of low‑margin generic products is increasing, and the market is shifting toward price competition.
Price competition
With fewer differentiated chemistries and a growing number of generics, competition has moved from agronomic performance to price. This shift has triggered sustained price wars in Germany, France, Spain, Italy, Poland and the United Kingdom. Margin compression is now a structural feature that affects manufacturers, distributors, cooperatives and advisory services alike.
Lower options for farmer
Farmers need reliable, high‑performance tools to protect yields against climate‑induced stresses and evolving pest pressures. However, the combined effect of stringent regulation and relentless price pressure erodes incentives for research, stewardship and compliance. Consequently, growers risk losing access to modern, effective solutions if the market continues to favor low‑cost, off‑patent products.
Summary
European agriculture stands at a crossroads. While EU regulation has undeniably raised safety and environmental standards, it has also reshaped market incentives, privileging short‑term price competition over long‑term innovation. The central question for R&D suppliers and ingredient providers is how to reconcile rigorous regulation with a viable pipeline of innovative, profitable products.
At Schlegel und Partner we specialize in turning market complexity into actionable strategies. We offer comprehensive market analysis and B2B market exploration through primary research and in-depth exchanges with global market experts. Our capabilities include perception analysis, benchmarking, and accurate market size calculations to quantify opportunities. We provide data‑driven trend analyses that help you navigate future developments and optimize positioning. Finally, we facilitate evidence‑based decision-making to accelerate your growth and market impact.
We are market experts and are happy to help you navigate this evolving landscape.
Are you interested in further information?
Please do not hesitate to contact us:
Dr. Isabelle Symonds
+49 6201 9915 10
Isabelle.Symonds@SchlegelundPartner.de
Nattaly Bruschi
+49 6201 9915 19
Nattaly.Bruschi@SchlegelundPartner.de
© Schlegel und Partner 2026